This is to provide you with important information regarding Dextran 40 (10% LMD in 0.9% Sodium Chloride Injection), which is indicated to enhance blood flow, particularly in the microcirculation, and is manufactured by Hospira Inc., a Pfizer company.
Based upon FDA’s evaluation of stability data, FDA has extended the expiration date on one lot of 10% LMD in 0.9% Sodium Chloride Injection (#07011JT) in 500 mL bags for 11 months beyond its expiry date, as follows:
#07011JT: from July 1, 2021, to June 1, 2022.
The FDA is not requiring or recommending that the lots identified above be relabeled with new expiration dates. If you have bags of lot #07011JT in your current inventory, labeled with an expiration date of July 1, 2021, you may continue to maintain the product in your inventory and keep it available for use until June 1, 2022.
Please use available inventory on a first-in, first-out basis through the new expiration dates as noted above.